School of Medicine


Showing 1-10 of 13 Results

  • Thomas Rando, MD, PhD

    Thomas Rando, MD, PhD

    Professor of Neurology

    Current Research and Scholarly Interests Our laboratory studies the molecular mechanisms regulating stem cell function, the effects of aging on skeletal muscle and skeletal muscle stem cells, and the pathogenesis and experimental therapeutics for hereditary muscle diseases, specifically the muscular dystrophies.

  • Lindsey Rasmussen

    Lindsey Rasmussen

    Clinical Assistant Professor, Pediatrics - Critical Care

    Current Research and Scholarly Interests My research interests reside in the field of Neurocritical Care Medicine. My research focus has included inflammation following traumatic brain injury, outcome prediction after cardiac arrest, and neuro-monitoring in the pediatric intensive care setting. These interests are integrated clinically to focus on the merging of specialized neurologic monitoring and care with prognostic efforts in critically ill patients.

  • Ashley Elaine Rawls

    Ashley Elaine Rawls

    Clinical Instructor, Neurology & Neurological Sciences

    Bio Dr. Ashley Rawls received her bachelor's degree in Biology at Duke University. Subsequently, she earned a master's degree in Medical Sciences with a concentration in Aging and Neuroscience at the University of South Florida Morsani College of Medicine. She went on to obtain her medical degree from the University of Florida College of Medicine. She completed neurology residency at the Medical University of South Carolina, where she was appointed neurology Chief Resident. Dr. Rawls is currently training in the Stanford University Movement Disorders fellowship program, and hopes to continue to pursue her interests in global health and medical education.

  • Babak Razavi

    Babak Razavi

    Clinical Assistant Professor, Neurology & Neurological Sciences

    Bio Dr. Razavi's clinical interests are in medically refractory epilepsies and using high density EEG (electroencephalogram) for better localization of seizure foci. His research areas include using engineering techniques for analyzing EEGs, medical devices for evaluation and treatment of epilepsy, and using seizures as a model for understanding consciousness.

  • Lawrence Recht, MD

    Lawrence Recht, MD

    Professor of Neurology and, by courtesy, of Neurosurgery at the Stanford University Medical Center

    Current Research and Scholarly Interests Our laboratory focuses on two interrelated projects: (1) assessment of glioma development within the framework of the multistage model of carcinogenesis through utilization of the rodent model of ENU neurocarcinogenesis; and (2) assessment of stem cell specification and pluripotency using an embryonic stem cell model system in which neural differentiation is induced.

  • Richard J. Reimer, MD

    Richard J. Reimer, MD

    Associate Professor of Neurology and, by courtesy, of Molecular and Cellular Physiology at the Palo Alto Veterans Administration Health Care System

    Current Research and Scholarly Interests Reimer Lab interests

    A primary interest of our lab is to understand how nerve cells make and recycle neurotransmitters, the small molecules that they use to communicate with each other. In better defining these processes we hope to achieve our long-term goal of identifying novel sites for treatment of diseases such as epilepsy and Parkinson Disease. In our studies on neurotransmitter metabolism we have focused our efforts on transporters, a functional class of proteins that move neurotransmitters and other small molecules across membranes in cells. Transporters have many characteristics that make them excellent pharmacological targets, and not surprisingly some of the most effective treatments for neuropsychiatric disorders are directed at transporters. We are specifically focusing on two groups of transporters – vesicular neurotransmitter transporters that package neurotransmitters into vesicles for release, and glutamine transporters that shuttle glutamine, a precursor for two major neurotransmitters glutamate and GABA, to neurons from glia, the supporting cells that surround them. We are pursuing these goals through molecular and biochemical studies, and, in collaboration with the Huguenard and Prince labs, through physiological and biosensor based imaging studies to better understand how pharmacological targeting of these molecules will influence neurological disorders.

    A second interest of our lab is to define mechanism underlying the pathology of lysosomal storage disorders. Lysosomes are membrane bound acidic intracellular organelles filled with hydrolytic enzymes that normally function as recycling centers within cells by breaking down damaged cellular macromolecules. Several degenerative diseases designated as lysosomal storage disorders (LSDs) are associated with the accumulation of material within lysosomes. Tay-Sachs disease, Neimann-Pick disease and Gaucher disease are some of the more common LSDs. For reasons that remain incompletely understood, these diseases often affect the nervous system out of proportion to other organs. As a model for LSDs we are studying the lysosomal free sialic acid storage disorders. These diseases are the result of a defect in transport of sialic acid across lysosomal membranes and are associated with mutations in the gene encoding the sialic acid transporter sialin. We are using molecular, genetic and biochemical approaches to better define the normal function of sialin and to determine how loss of sialin function leads to neurodevelopmental defects and neurodegeneration associated with the lysosomal free sialic acid storage disorders.

Footer Links:

Stanford Medicine Resources: